aod 9604 vs hgh frag 176-191

aod 9604 (D-tier) vs hgh frag 176-191 (C-tier). mechanism, trials, evidence boundaries, dosing literature. side-by-side reference.

aod 9604 · tier D

HGH fragment. went to phase 2b for obesity. failed. the data says it doesn't work.

HGH fragment. went to phase 2b for obesity. failed. the data says it doesn't work for the marketed indication.

frag 176-191 phase 2b · failed · half-life plasma half-life extended versus unmodified fragment; lipolytic effects acute and dose-dependent · weight loss

hgh frag 176-191 · tier C

HGH fragment 176-191. sold as 'fat loss without growth.' the AOD9604 trial that tested this idea failed.

HGH fragment 176-191. sold as 'fat loss without growth.' the AOD9604 trial that tested exactly that idea failed in phase 2b.

176-191 AOD-9604 parent · half-life approximately 30 minutes plasma half-life; no validated human dosing schedule · growth hormone

at a glance

• aod 9604: tier D · frag 176-191 phase 2b · failed
• hgh frag 176-191: tier C · 176-191 AOD-9604 parent

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.